0000899243-20-033757.txt : 20201214 0000899243-20-033757.hdr.sgml : 20201214 20201214171611 ACCESSION NUMBER: 0000899243-20-033757 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Gilmore Neil CENTRAL INDEX KEY: 0001742084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38470 FILM NUMBER: 201387074 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unity Biotechnology, Inc. CENTRAL INDEX KEY: 0001463361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264726035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (415) 328-5504 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Cenexys, Inc. DATE OF NAME CHANGE: 20130703 FORMER COMPANY: FORMER CONFORMED NAME: Forge Inc DATE OF NAME CHANGE: 20090504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001463361 Unity Biotechnology, Inc. UBX 0001742084 O'Neill Gilmore Neil C/O UNITY BIOTECHNOLOGY, INC. 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO 94080 1 0 0 0 Stock Option (Right to Buy) 6.12 2020-12-10 4 A 0 50000 0.00 A 2030-12-09 Common Stock 50000 50000 D Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on December 10, 2020 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Anirvan Ghosh, Attorney-in-Fact for Gilmore O'Neill 2020-12-14